222 related articles for article (PubMed ID: 2538653)
21. Efficient transcription of the Epstein-Barr virus immediate-early BZLF1 and BRLF1 genes requires protein synthesis.
Flemington EK; Goldfeld AE; Speck SH
J Virol; 1991 Dec; 65(12):7073-7. PubMed ID: 1658397
[TBL] [Abstract][Full Text] [Related]
22. An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat.
Kenney S; Kamine J; Markovitz D; Fenrick R; Pagano J
Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1652-6. PubMed ID: 2830625
[TBL] [Abstract][Full Text] [Related]
23. Polymorphisms of the region of the Epstein-Barr virus genome which disrupts latency.
Jenson HB; Miller G
Virology; 1988 Aug; 165(2):549-64. PubMed ID: 2841800
[TBL] [Abstract][Full Text] [Related]
24. The Epstein-Barr virus immediate-early promoter BRLF1 can be activated by the cellular Sp1 transcription factor.
Zalani S; Holley-Guthrie EA; Gutsch DE; Kenney SC
J Virol; 1992 Dec; 66(12):7282-92. PubMed ID: 1331521
[TBL] [Abstract][Full Text] [Related]
25. Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency.
Rooney C; Taylor N; Countryman J; Jenson H; Kolman J; Miller G
Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9801-5. PubMed ID: 2849118
[TBL] [Abstract][Full Text] [Related]
26. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE
J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
[TBL] [Abstract][Full Text] [Related]
27. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
Nilsson T; Sjöblom A; Masucci MG; Rymo L
Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells.
Sugiura M; Imai S; Tokunaga M; Koizumi S; Uchizawa M; Okamoto K; Osato T
Br J Cancer; 1996 Aug; 74(4):625-31. PubMed ID: 8761381
[TBL] [Abstract][Full Text] [Related]
29. Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter.
Chevallier-Greco A; Manet E; Chavrier P; Mosnier C; Daillie J; Sergeant A
EMBO J; 1986 Dec; 5(12):3243-9. PubMed ID: 3028777
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.
Tierney RJ; Steven N; Young LS; Rickinson AB
J Virol; 1994 Nov; 68(11):7374-85. PubMed ID: 7933121
[TBL] [Abstract][Full Text] [Related]
31. Role of the TSG101 gene in Epstein-Barr virus late gene transcription.
Chua HH; Lee HH; Chang SS; Lu CC; Yeh TH; Hsu TY; Cheng TH; Cheng JT; Chen MR; Tsai CH
J Virol; 2007 Mar; 81(5):2459-71. PubMed ID: 17182691
[TBL] [Abstract][Full Text] [Related]
32. Strain variation in Epstein-Barr virus immediate early genes.
Packham G; Brimmell M; Cook D; Sinclair AJ; Farrell PJ
Virology; 1993 Feb; 192(2):541-50. PubMed ID: 8093650
[TBL] [Abstract][Full Text] [Related]
33. Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.
Quinlivan EB; Holley-Guthrie EA; Norris M; Gutsch D; Bachenheimer SL; Kenney SC
Nucleic Acids Res; 1993 Jul; 21(14):1999-2007. PubMed ID: 8393562
[TBL] [Abstract][Full Text] [Related]
34. A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen.
Hardwick JM; Lieberman PM; Hayward SD
J Virol; 1988 Jul; 62(7):2274-84. PubMed ID: 2836611
[TBL] [Abstract][Full Text] [Related]
35. The Zif268 cellular transcription factor activates expression of the Epstein-Barr virus immediate-early BRLF1 promoter.
Zalani S; Holley-Guthrie E; Kenney S
J Virol; 1995 Jun; 69(6):3816-23. PubMed ID: 7745729
[TBL] [Abstract][Full Text] [Related]
36. Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.
Feng WH; Westphal E; Mauser A; Raab-Traub N; Gulley ML; Busson P; Kenney SC
J Virol; 2002 Nov; 76(21):10951-9. PubMed ID: 12368338
[TBL] [Abstract][Full Text] [Related]
37. Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region.
Marquitz AR; Mathur A; Edwards RH; Raab-Traub N
J Virol; 2015 Nov; 89(22):11256-68. PubMed ID: 26311882
[TBL] [Abstract][Full Text] [Related]
38. The Epstein-Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and R.
Buisson M; Manet E; Trescol-Biemont MC; Gruffat H; Durand B; Sergeant A
J Virol; 1989 Dec; 63(12):5276-84. PubMed ID: 2555554
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr-virus-infected human T-cell line with a unique pattern of viral-gene expression.
Nakamura H; Iwakiri D; Ono Y; Fujiwara S
Int J Cancer; 1998 May; 76(4):587-94. PubMed ID: 9590138
[TBL] [Abstract][Full Text] [Related]
40. Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection.
Zetterberg H; Stenglein M; Jansson A; Ricksten A; Rymo L
J Gen Virol; 1999 Feb; 80 ( Pt 2)():457-466. PubMed ID: 10073708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
